XSHG603990
Market cap540mUSD
Jan 10, Last price
12.98CNY
1D
10.00%
1Q
28.13%
Jan 2017
-27.49%
IPO
160.12%
Name
Suzhou MedicalSystem Technology Co Ltd
Chart & Performance
Profile
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive auxiliary diagnosis clinical information system that mines and scientifically analyzes for ICU patients' treatment data with medical information, such as patients' treatment information, inspection information, nursing information, and doctor's advice data. In addition, it offers DoCare operative medical behavior management system that establishes the intelligent management system for the operation resources and personnel behavior; and DoCare emergency clinical information system for management of emergency clinical, including pre-hospital first aid, pre-examination and triage, emergency rescue, emergency under observation, emergency operating room, emergency ICU, and patient outcome. Further, the company provides DoCare pre-hospital first aid clinical information system that provides a unified service platform, which has digital information for emergency command center, emergency doctors, emergency nurses, visiting medical personnel, and patients. Additionally, it offers smart OT, ICU, and emergency solutions; and smart specialty solutions, such as laminar airflow room, clinical pathway, and mobile nursing information systems, as well as central sterile supply department management systems. The company was founded in 2005 and is based in Suzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 618,141 102.33% | 305,507 -13.66% | |||||||
Cost of revenue | 675,958 | 218,036 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (57,816) | 87,472 | |||||||
NOPBT Margin | 28.63% | ||||||||
Operating Taxes | 3,253 | 8,067 | |||||||
Tax Rate | 9.22% | ||||||||
NOPAT | (61,070) | 79,405 | |||||||
Net income | 33,561 -20.01% | ||||||||
Dividends | (17,571) | ||||||||
Dividend yield | 0.44% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 517,794 | 157,226 | |||||||
Long-term debt | 1,483,771 | 11,911 | |||||||
Deferred revenue | 313 | 660 | |||||||
Other long-term liabilities | 135,892 | 976 | |||||||
Net debt | 1,480,934 | (802,276) | |||||||
Cash flow | |||||||||
Cash from operating activities | (316,649) | 50,513 | |||||||
CAPEX | (599,837) | ||||||||
Cash from investing activities | (862,530) | 205,316 | |||||||
Cash from financing activities | 710,158 | 307,416 | |||||||
FCF | (1,962,989) | 93,216 | |||||||
Balance | |||||||||
Cash | 638,294 | 971,413 | |||||||
Long term investments | (117,662) | ||||||||
Excess cash | 489,724 | 956,137 | |||||||
Stockholders' equity | 348,103 | 595,763 | |||||||
Invested Capital | 2,226,777 | 918,512 | |||||||
ROIC | 9.98% | ||||||||
ROCE | 5.78% | ||||||||
EV | |||||||||
Common stock shares outstanding | 306,158 | 272,679 | |||||||
Price | 12.92 -11.93% | 14.67 11.31% | |||||||
Market cap | 3,955,566 -1.12% | 4,000,201 10.09% | |||||||
EV | 5,439,779 | 3,201,575 | |||||||
EBITDA | (24,100) | 104,314 | |||||||
EV/EBITDA | 30.69 | ||||||||
Interest | 48,766 | 3,971 | |||||||
Interest/NOPBT | 4.54% |